Copyright Reports & Markets. All rights reserved.

Post-pandemic Era-Global Biotechnology Separation Systems Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026

Buy now

Table of Contents

    Global Biotechnology Separation Systems Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

      1 Market Scope

      • 1.1 Product Details and Introduction
        • 1.1.1 Membrane Filtration -Product Introduction and Major Manufacturers
        • 1.1.2 Chromatography -Product Introduction and Major Manufacturers
        • 1.1.3 Centrifuge -Product Introduction and Major Manufacturers
        • 1.1.4 Electrophoresis -Product Introduction and Major Manufacturers
        • 1.1.5 Flow Cytometry -Product Introduction and Major Manufacturers
        • 1.1.6 Others -Product Introduction and Major Manufacturers
      • 1.2 Market Snapshot
        • 1.2.1 Major Companies Overview
        • 1.2.2 Market Concentration
        • 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

      2 Global Biotechnology Separation Systems Market Assessment, by Segmentation

      • 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
      • 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
      • 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)

      3 Regional Market Analysis

      • 3.1 China Biotechnology Separation Systems Market
        • 3.1.1 Top Companies leading Biotechnology Separation Systems Development in China (2015-2020)
        • 3.1.2 Sales Value of Major Company in China Market (2015-2020)
        • 3.1.3 China Biotechnology Separation Systems Price (USD/Unit), by Type (2019-2020)
        • 3.1.4 Sales in China Market, by Type (2015-2026)
      • 3.2 EU Biotechnology Separation Systems Market
        • 3.2.1 Top Companies leading Biotechnology Separation Systems Development in EU (2015-2020)
        • 3.2.2 Sales Value of Major Company in EU Market (2015-2020)
        • 3.2.3 EU Biotechnology Separation Systems Price (USD/Unit), by Type (2019-2020)
        • 3.2.4 Sales in EU Market, by Type (2015-2026)
      • 3.3 USA Biotechnology Separation Systems Market
        • 3.3.1 Top Companies leading Biotechnology Separation Systems Development in USA (2015-2020)
        • 3.3.2 Sales Value of Major Company in USA Market (2015-2020)
        • 3.3.3 USA Biotechnology Separation Systems Price (USD/Unit), by Type (2019-2020)
        • 3.3.4 Sales in USA Market, by Type (2015-2026)
      • 3.4 Japan Biotechnology Separation Systems Market
        • 3.4.1 Top Companies leading Biotechnology Separation Systems Development in Japan (2015-2020)
        • 3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
        • 3.4.3 Japan Biotechnology Separation Systems Price (USD/Unit), by Type (2019-2020)
        • 3.4.4 Sales in Japan Market, by Type (2015-2026)
      • 3.5 India Biotechnology Separation Systems Market
        • 3.5.1 Top Companies leading Biotechnology Separation Systems Development in India (2015-2020)
        • 3.5.2 Sales Value of Major Company in India Market (2015-2020)
        • 3.5.3 India Biotechnology Separation Systems Price (USD/Unit), by Type (2019-2020)
        • 3.5.4 Sales in India Market, by Type (2015-2026)
      • 3.6 Southeast Asia Biotechnology Separation Systems Market
        • 3.6.1 Top Companies leading Biotechnology Separation Systems Development in Southeast Asia (2015-2020)
        • 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
        • 3.6.3 Southeast Asia Biotechnology Separation Systems Price (USD/Unit), by Type (2019-2020)
        • 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
      • 3.7 South America Biotechnology Separation Systems Market
        • 3.7.1 Top Companies leading Biotechnology Separation Systems Development in South America (2015-2020)
        • 3.7.2 Sales Value of Major Company in South America Market (2015-2020)
        • 3.7.3 South America Biotechnology Separation Systems Price (USD/Unit), by Type (2019-2020)
        • 3.7.4 Sales in South America Market, by Type (2015-2026)

      4 Value Chain (Impact of COVID-19)

      • 4.1 Biotechnology Separation Systems Value Chain Analysis
        • 4.1.1 Upstream
        • 4.1.2 Downstream
      • 4.2 COVID-19 Impact on Biotechnology Separation Systems Industry
        • 4.2.1 Industrial Policy Issued Under the Epidemic Situation
      • 4.3 Cost-Under the Epidemic Situation
        • 4.3.1 Cost of Raw Material
      • 4.4 Channel Analysis
        • 4.4.1 Distribution Channel-Under the Epidemic Situation
        • 4.4.2 Distributors

      5 Regional Market Forecast (2021-2026)

      • 5.1 Global Biotechnology Separation Systems Sales and Growth Rate (2021-2026)
      • 5.2 Global Biotechnology Separation Systems Sales Value and Growth Rate (2021-2026)

      6 Biotechnology Separation Systems Competitive Analysis

      • 6.1 Danaher
        • 6.1.1 Danaher Company Profiles
        • 6.1.2 Danaher Product Introduction
        • 6.1.3 Danaher Biotechnology Separation Systems Production, Revenue (2015-2020)
        • 6.1.4 SWOT Analysis
      • 6.2 Thermo Fisher Scientific
        • 6.2.1 Thermo Fisher Scientific Company Profiles
        • 6.2.2 Thermo Fisher Scientific Product Introduction
        • 6.2.3 Thermo Fisher Scientific Biotechnology Separation Systems Production, Revenue (2015-2020)
        • 6.2.4 SWOT Analysis
      • 6.3 BD
        • 6.3.1 BD Company Profiles
        • 6.3.2 BD Product Introduction
        • 6.3.3 BD Biotechnology Separation Systems Production, Revenue (2015-2020)
        • 6.3.4 SWOT Analysis
      • 6.4 Merck
        • 6.4.1 Merck Company Profiles
        • 6.4.2 Merck Product Introduction
        • 6.4.3 Merck Biotechnology Separation Systems Production, Revenue (2015-2020)
        • 6.4.4 SWOT Analysis
      • 6.5 GE Healthcare
        • 6.5.1 GE Healthcare Company Profiles
        • 6.5.2 GE Healthcare Product Introduction
        • 6.5.3 GE Healthcare Biotechnology Separation Systems Production, Revenue (2015-2020)
        • 6.5.4 SWOT Analysis
      • 6.6 Agilent
        • 6.6.1 Agilent Company Profiles
        • 6.6.2 Agilent Product Introduction
        • 6.6.3 Agilent Biotechnology Separation Systems Production, Revenue (2015-2020)
        • 6.6.4 SWOT Analysis
      • 6.7 Sysmex
        • 6.7.1 Sysmex Company Profiles
        • 6.7.2 Sysmex Product Introduction
        • 6.7.3 Sysmex Biotechnology Separation Systems Production, Revenue (2015-2020)
        • 6.7.4 SWOT Analysis
      • 6.8 Alfa Wassermann
        • 6.8.1 Alfa Wassermann Company Profiles
        • 6.8.2 Alfa Wassermann Product Introduction
        • 6.8.3 Alfa Wassermann Biotechnology Separation Systems Production, Revenue (2015-2020)
        • 6.8.4 SWOT Analysis
      • 6.9 Shimadzu
        • 6.9.1 Shimadzu Company Profiles
        • 6.9.2 Shimadzu Product Introduction
        • 6.9.3 Shimadzu Biotechnology Separation Systems Production, Revenue (2015-2020)
        • 6.9.4 SWOT Analysis
      • 6.10 Sartorius Stedim Biotech
        • 6.10.1 Sartorius Stedim Biotech Company Profiles
        • 6.10.2 Sartorius Stedim Biotech Product Introduction
        • 6.10.3 Sartorius Stedim Biotech Biotechnology Separation Systems Production, Revenue (2015-2020)
        • 6.10.4 SWOT Analysis
      • 6.11 Illumina
      • 6.12 Waters
      • 6.13 Novasep
      • 6.14 3M Purification
      • 6.15 Affymetrix
      • 6.16 Bio-Rad Laboratories
      • 6.17 Alfa Laval
      • 6.18 PerkinElmer
      • 6.19 Repligen
      • 6.20 Hitachi Koki

      7 Conclusion

      Summary

      As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

      Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
      In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
      Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
      Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Biotechnology Separation Systems market in this environment.

      In terms of revenue, this research report indicated that the global Biotechnology Separation Systems market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Biotechnology Separation Systems industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

      The ????Danaher aims at producing XX Biotechnology Separation Systems in 2020, with XX % production to take place in global market, ????Thermo Fisher Scientific accounts for a volume share of XX %.

      Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Biotechnology Separation Systems Market by XYZResearch Include
      China
      EU
      USA
      Japan
      India
      Southeast Asia
      South America
      Competitive Analysis; Who are the Major Players in Biotechnology Separation Systems Market?
      Danaher
      Thermo Fisher Scientific
      BD
      Merck
      GE Healthcare
      Agilent
      Sysmex
      Alfa Wassermann
      Shimadzu
      Sartorius Stedim Biotech
      Illumina
      Waters
      Novasep
      3M Purification
      Affymetrix
      Bio-Rad Laboratories
      Alfa Laval
      PerkinElmer
      Repligen
      Hitachi Koki
      ...
      Major Type of Biotechnology Separation Systems Covered in XYZResearch report:
      Membrane Filtration
      Chromatography
      Centrifuge
      Electrophoresis
      Flow Cytometry
      Others
      Application Segments Covered in XYZResearch Market
      Commercial
      Scientific Research
      Application 3

      For any other requirements, please feel free to contact us and we will provide you customized report.

      Buy now